Biopharma News

Dec 19, 2013
By BioPharm International Editors
ProBioGen signs agreement with Emergent BioSolutions for access to ProBioGen's avian AGE1.CR cell line.
Dec 19, 2013
By BioPharm International Editors
Siemens enters agreement with Pfizer to commercialize diagnostic tests for therapeutic products across Pfizer's pipeline.
Dec 19, 2013
By BioPharm International Editors
Pfizer appoints management changes to take effect in 2014.
Dec 17, 2013
By BioPharm International Editors
Merck's new facility for aseptic production in Reinbek, Germany is scheduled to be completed in 2016.
Dec 17, 2013
By BioPharm International Editors
AstraZeneca's MedImmune will collaborate with Johns Hopkins University in both biologics and small-molecule projects.
Dec 12, 2013
By BioPharm International Editors
Bristol-Myers Squibb has elected Thomas Lynch, Jr., MD to its board of directors.
Dec 12, 2013
By BioPharm International Editors
GSK forms the Oncology Clinical and Translational Consortium, a scientific research network comprised of six international cancer centers.
Dec 12, 2013
By BioPharm International Editors
Octapharma and Pfizer form an agreement for the future marketing and commercialization of human prothrombin complex concentrate.
Dec 12, 2013
By BioPharm International Editors
Johnson&Johnson will open a network of partnering offices across the UK.
Nov 27, 2013
By BioPharm International Editors
Additional companies join Merck KGaA and Neviah Genomics in the Israel BioIncubator.
native1_300x100
lorem ipsum